Neuried, Germany: AMSilk GmbH, a frontrunner in advanced biomaterials made from silk-based proteins, on Tuesday announced it has successfully secured EUR 52 million financing led by existing investor ATHOS (AT Newtec), along with strong participation from fellow existing investors MIG Capital and Novo Holdings. The financing combines EUR 30 million...
